Science News
from research organizations

Unusual Metals Could Forge New Cancer Drug

Date:
October 19, 2009
Source:
University of Warwick
Summary:
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to new research.
Share:
         
Total shares:  
FULL STORY

Professor Peter Sadler of the University of Warwick.
Credit: University of Warwick

Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds.

The study, published in the Journal of Medicinal Chemistry, showed that a range of compounds containing the two transition metals Ruthenium and Osmium, which are found in the same part of the periodic table as precious metals like platinum and gold, cause significant cell death in ovarian and colon cancer cells.

The compounds were also effective against ovarian cancer cells which are resistant to the drug Cisplatin, the most successful transition metal drug, which contains the metal platinum.

Dr Patrick McGowan, one of the lead authors of the research from the School of Chemistry at the University of Leeds, explains: "Ruthenium and Osmium compounds are showing very high levels of activity against ovarian cancer, which is a significant step forward in the field of medicinal chemistry.

Sabine H. van Rijt, lead researcher in the laboratory of Professor Peter Sadler in the Department of Chemistry at the University of Warwick, said:

"Most interestingly, cancerous cells that have shown resistance to the most successful transition metal drug, Cisplatin, show a high death rate with these new compounds."

Professor Sadler, at the University of Warwick, commented that he is "excited by the novel design features in these compounds which might enable activity to be switched on and off".

Cisplatin was discovered in the 1970s and is one of the most effective cancer drugs on the market, with a 95% cure rate against testicular cancer. Since the success of Cisplatin, chemists all over the world have been trying to discover whether other transition metal compounds can be used to treat cancer.

In this type of anti cancer drug transition metal atoms bind to DNA molecules which trigger apoptosis, or programmed cell death, in the cancerous cells.

The study is a collaboration between the universities of Warwick and Leeds and was funded by the Engineering and Physical Sciences Research Council (EPSRC).


Story Source:

The above story is based on materials provided by University of Warwick. Note: Materials may be edited for content and length.


Journal Reference:

  1. van Rijt et al. Amide Linkage Isomerism As an Activity Switch for Organometallic Osmium and Ruthenium Anticancer Complexes. Journal of Medicinal Chemistry, 2009; 090930083513062 DOI: 10.1021/jm900731j

Cite This Page:

University of Warwick. "Unusual Metals Could Forge New Cancer Drug." ScienceDaily. ScienceDaily, 19 October 2009. <www.sciencedaily.com/releases/2009/10/091019123107.htm>.
University of Warwick. (2009, October 19). Unusual Metals Could Forge New Cancer Drug. ScienceDaily. Retrieved May 4, 2015 from www.sciencedaily.com/releases/2009/10/091019123107.htm
University of Warwick. "Unusual Metals Could Forge New Cancer Drug." ScienceDaily. www.sciencedaily.com/releases/2009/10/091019123107.htm (accessed May 4, 2015).

Share This Page:


Recommended Content
 


Health & Medicine News
May 4, 2015

Latest Headlines
updated 12:56 pm ET